SHEFFIELD, United Kingdom, Jan. 8, 2025 /PRNewswire/ -- BlackfinBio Ltd (BFB) a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases has announced today that it has acquired the Parkinson's patent portfolio from OXB. BlackfinBio Ltd...
Hence then, the article about blackfinbio ltd announces the acquisition of parkinson s ip patent portfolio from oxb was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( BlackfinBio Ltd announces the acquisition of Parkinson's IP patent portfolio from OXB )
Also on site :
- Valeo inicia la construcción de una planta de alta tecnología de $225 millones en McAllen, Texas, dedicada al desarrollo de tecnología de vehículos definidos por software
- Labor & Employment Law Firm Zakay Law Group, APLC Files a Class Action Against Horizon Aviation and Matrix Aviation, Alleging Failure to Provide Meal and Rest Breaks
- SAFE Structure Designs Transitions Patented SAFE MULE Expeditionary Logistics Platform into Production for U.S. Military Operations